IRIS - Res&Arch Institutional Research Information System - Research & Archive

CIPRIANI, Sabrina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.337
EU - Europa 1.501
AS - Asia 1.451
SA - Sud America 226
AF - Africa 25
OC - Oceania 4
Totale 5.544
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.280
SG - Singapore 658
IE - Irlanda 318
IT - Italia 278
CN - Cina 236
HK - Hong Kong 229
BR - Brasile 199
VN - Vietnam 181
RU - Federazione Russa 174
UA - Ucraina 156
SE - Svezia 127
FI - Finlandia 92
DE - Germania 86
GB - Regno Unito 58
FR - Francia 57
TR - Turchia 42
EE - Estonia 36
CA - Canada 28
KR - Corea 27
MX - Messico 22
IN - India 21
PL - Polonia 21
CH - Svizzera 15
AT - Austria 14
RO - Romania 14
JP - Giappone 13
NL - Olanda 12
AR - Argentina 10
BE - Belgio 10
ES - Italia 10
CZ - Repubblica Ceca 9
ZA - Sudafrica 9
BD - Bangladesh 7
LB - Libano 6
UZ - Uzbekistan 6
CO - Colombia 5
EC - Ecuador 5
KE - Kenya 5
PK - Pakistan 5
GR - Grecia 4
CL - Cile 3
HN - Honduras 3
IQ - Iraq 3
KG - Kirghizistan 3
LT - Lituania 3
MA - Marocco 3
AU - Australia 2
BN - Brunei Darussalam 2
DZ - Algeria 2
EG - Egitto 2
HU - Ungheria 2
NO - Norvegia 2
PH - Filippine 2
TW - Taiwan 2
VE - Venezuela 2
AL - Albania 1
AO - Angola 1
CR - Costa Rica 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
ID - Indonesia 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
KH - Cambogia 1
LU - Lussemburgo 1
MN - Mongolia 1
NG - Nigeria 1
NP - Nepal 1
NR - Nauru 1
PA - Panama 1
PT - Portogallo 1
PW - Palau 1
SA - Arabia Saudita 1
SR - Suriname 1
SV - El Salvador 1
TN - Tunisia 1
UY - Uruguay 1
Totale 5.544
Salva come PNG Salva come JPEG
Città #
Singapore 434
Chandler 396
Dublin 317
Hong Kong 228
San Mateo 193
Dong Ket 134
Perugia 108
Ashburn 105
Boardman 101
Santa Clara 97
Ann Arbor 90
Altamura 88
Medford 78
Princeton 78
Beijing 73
Jacksonville 69
Lawrence 69
Moscow 65
Wilmington 64
Andover 63
Los Angeles 48
Columbus 33
Izmir 31
New York 29
São Paulo 29
Des Moines 27
Saint Petersburg 27
Seoul 27
Munich 23
Dearborn 21
Helsinki 21
Ho Chi Minh City 19
The Dalles 17
Houston 16
Timisoara 14
Warsaw 14
Stockholm 13
San Paolo di Civitate 12
Tokyo 12
Dallas 11
London 11
Norwalk 11
Redmond 11
Brussels 10
Chicago 10
Falls Church 10
Manchester 9
Toronto 9
Vienna 9
Woodbridge 9
Chennai 8
Den Haag 8
Denver 8
Mexico City 8
Nuremberg 8
Turku 8
Frankfurt am Main 7
Montreal 7
Olomouc 7
Redwood City 7
Rio de Janeiro 7
Rome 7
Ankara 6
Boston 6
Hanoi 6
Johannesburg 6
Nairobi 5
Phoenix 5
Brooklyn 4
Nanjing 4
Orem 4
Ribeirão Preto 4
San Francisco 4
Seattle 4
Atlanta 3
Bishkek 3
Carney 3
City of London 3
Giugliano In Campania 3
Guayaquil 3
New Delhi 3
Ninh Bình 3
Ottawa 3
Philadelphia 3
Piscataway 3
Poplar 3
Salvador 3
Shanghai 3
Vancouver 3
Americana 2
Antakya 2
Araruama 2
Arezzo 2
Bandar Seri Begawan 2
Barra Mansa 2
Bauru 2
Belo Horizonte 2
Betim 2
Bexley 2
Bucaramanga 2
Totale 3.608
Salva come PNG Salva come JPEG
Nome #
The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines 119
Anti-HIV Protease Inhibitors Interact With NSAIDs and Exacerbate Small Intestine Enteropathy Induced by NSAIDs 119
The bile acid receptor GPBAR1 regulates the M1/M2 phenotype of intestinal macrophages and activation of gpbar1 rescues mice from murine colitis 118
BAR502, a Dual FXR and GPBAR1 Agonist, Reverses Steatosis and Fibrosis in Rodent Model of NASH By Modulating Authophagic Genes 116
Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice. 114
Activation of the bile acid receptor GPBAR1 protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs and aspirin in mice. 114
Bile acid-activated receptors in the treatment of dyslipidemia and related disorders. 112
Leflunomide protects against dyslipidemia development induced by ritonavir in mice 112
A Comprehensive Analysis of Small Heterodimer Partner (SHP) Target Genes in Hepatic Stellate Cells and the Discovery of a New Class of SHP Agonists That Reduces Liver Fibrosis 111
Activation of FXR Improves Myocardial Fatty Acid Metabolism in a Rodent Model of Liver Steatosis 105
BAR 501, a Novel GPBAR1 Ligand, Reverses Intestinal and Liver Inflammatory Models Demonstrating That GPBAR1 Is an Essential Modulator of Innate Immunity in Entero-Hepatic Tissues 104
Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. 103
BAR501, A SELECTIVE GPBAR1 AGONIST, PROMOTES ADIPOSE TISSUE BROWNING AND AUTOPHAGY AND IMPROVES LIPID METABOLISM AND STEATO-HEPATITIS IN MICE FEED A HIGH FAT DIET 96
Microencapsulated G3C hybridoma cell graft delays the onset of spontaneous diabetes in NOD mice by an expansion of Gitr+ Treg cells 94
Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition 92
Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents. 90
BAR130, A HYODEOXYCHOLIC ACID DERIVATIVE AS THE FIRST EXAMPLE OF DUAL LXR alpha/GPBAR1 AGONIST 90
A Platelet's Guide to Synovitis 88
Counter-regulatory role of bile acid activated receptors in immunity andinflammation. 85
BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis 83
Genetic and Pharmacological Dissection of the Role of Spleen Tyrosine Kinase (Syk) in Intestinal Inflammation and Immune Dysfunction in Inflammatory Bowel Diseases 83
A Novel Source of Intestinal Damage: The HIV Protease Inhibitor Ritonavir Worsens Damage Caused by COX Inhibitors 81
Discovery that theonellasterol a marine sponge sterol is a highly selective FXR antagonist that protects against liver injury in cholestasis. 81
Maraviroc Intensification Modulates Atherosclerotic Progression in HIV-Suppressed Patients at High Cardiovascular Risk. A Randomized, Crossover Pilot Study 81
Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatorybowel diseases and arthritis 80
Farnesoid X receptor suppresses constitutive androstane receptoractivity at the multidrug resistance protein-4 promoter. 79
Bile acid activated receptors are targets for regulation of integrity of gastrointestinal mucosa 79
Genetic Ablation and Pharmacological Blockade of CCR5 by the anti-HIV Small Molecule Inhibitor Maraviroc Inhibits Leukocyte Trafficking and Protects Against Mucosal Inflammation in Murine Models Colitis 77
The HIV Matrix Protein p17 subverts Nuclear Receptors Expression and induces a STAT1-Dependent Proinflammatory Phenotype in Monocytes 76
FXR mediates a chromatin looping in the GR promoter thus promoting the resolution of colitis in rodents. 76
DISCOVERY OF BAR704, A POTENT AND SELECTIVE FXR AGONIST, THAT PROTECTS AGAINST LIVER FIBROSIS 76
Ritonavir-induced lipoatrophy and dyslipidaemia is reversed by the anti-inflammatory drug leflunomide in a PPAR-γ-dependent manner. 74
Metabolic variability of a multispecies probiotic preparation impacts on the anti-inflammatory activity 74
Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation. 72
The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis. 71
The bile acid sensor FXR protects against dyslipidemia and aortic plaques development induced by the HIV protease inhibitor ritonavir in mice. 71
Farnesoid X receptor agonist for the treatment of liver and metabolic disorders: focus on 6-ethyl-CDCA 70
Exploitation of cholane scaffold for the discovery of potent and selective farnesoid X receptor (FXR) and G-protein coupled bile acid receptor 1 (GP-BAR1) ligands 70
Impaired Itching Perception in Murine Models of Cholestasis Is Supported by Dysregulation of GPBAR1 Signaling 70
CCR5 Antagonism by Maraviroc Reduces the Potential for Gastric Cancer Cell Dissemination. 67
Gpbar1 agonism promotes a Pgc-1α-dependent browning of white adipose tissue and energy expenditure and reverses diet-induced steatohepatitis in mice 67
The nuclear receptor FXR regulates hepatic transport and metabolism of glutamine and glutamate 66
The HIV Matrix Protein p17 promotes the Activation of human hepatic stellate cells through interactions with CXCR2 and Syndecan-2 66
Cystathionine gamma-lyase, a H2S-generating enzyme, is a GPBAR1-regulated gene and contributes to vasodilation caused by secondary bile acids 66
Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders. 66
VARIABILITY IN INDUSTRIAL PRODUCTION AFFECTS PROBIOTICS ACTIVITY: IDENTIFICATION OF BATCHES OF PROBIOTIC VSL#3 THAT INCREASES INTESTINAL PERMEABILITY AND WORSENS COLITIS IN RODENTS 65
GPBAR1 (TGR5) LIGATION PROTECTS AGAINST COLITIS DEVELOPMENT BY REGULATING LEUKOCYTE TRAFFINKING AND PROMOTING A IL-10 DEPENDENT SHIFT IN THE M1/M2 PHENOTYPE 64
Nanotraps with biomimetic surface as decoys for chemokines 63
The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis. 63
Hydrogen sulphide induces micro opioid receptor-dependent analgesia in a rodent model of visceral pain. 60
Targetting farnesoid-X-receptor: from medicinal chemistry to disease treatment. 60
In vivo administration of ritonavir worsens intestinal damage caused by cyclooxygease inhibitors. 60
SHP-dependent and -independent induction of peroxisomeproliferator-activated receptor-γ by the bile acid sensor farnesoid X receptorcounter-regulates the pro-inflammatory phenotype of liver myofibroblasts. 59
FXR Activation Reverses Insulin Resistance and Protects Against NASH Development 58
The Leukemic Isocitrate Dehydrogenase (IDH) 1/2 Mutations Impair Myeloid and Erythroid Cell Differentiation of Primary Human Hematopoietic Stem and Progenitor Cells (HSPCs) 57
Instruction of Intestinal Microbiota by VSL#3 Reverses NASH and Accelerated Atherosclerosis Caused by Intestinal Inflammation in ApoE(-/-) Mice 57
Decoding the role of the nuclear receptor SHP in regulating hepatic stellate cells and liver fibrogenesis 57
H2S Induces Analgesia Is Mediated In Vivo Activation of mu Opioid Receptor and PI3K/AKT Pathway Activation 56
Methotrexate improves endothelial function in early rheumatoid arthritis patients after 3 months of treatment 55
Pregnane-X-receptor mediates the anti-inflammatoryactivities of rifaximin on detoxification pathways in intestinal epithelialcells. 55
Targeting Bile Acid Receptors: Discovery of a Potent and Selective Farnesoid X Receptor Agonist as a New Lead in the Pharmacological Approach to Liver Diseases 55
Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1 55
Role of Maraviroc in a dyslipidemic murine model of atherosclerosis RTV-induced 53
Solomonsterol A, a marine pregnane-X-receptor agonist, attenuates inflammation and immune dysfunction in a mouse model of arthritis. 53
The HIV matrix protein p17 induces hepatic lipid accumulation via modulation of nuclear receptor transcriptoma 52
Essential Role of DNAX Adaptor Protein 12 (DAP12) and Spleen Tyrosine Kinase (Syk) in Inflammation-Driven Immune Dysfunction in Rodent Model of Colitis 49
Modulation of intestinal microbiota by the probiotic VSL#3 resets brain gene expression and ameliorates the age-related deficit in LTP. 48
Preterm Birth, Low Gestational Age, Low Birth Weight, Parity, and Other Determinants of Breech Presentation: Results from a Large Retrospective Population-Based Study 48
Reciprocal Regulation of TLRS and Nuclear Receptors: IRF-7 Dependent Regulation of FXR Mediates Counter-Regulatory Effects of TLR-9 in Colitis 46
Probiotics VSL#3 protect against development of visceral pain in murine model of irritable bowel syndrome. 46
Highly specific blockade of CCR5 inhibits leukocyte trafficking and reduces mucosal inflammation in murine colitis 46
Dietary habits and semen parameters: a systematic narrative review 46
The bile acid sensor FXR is required for immune-regulatory activities of TLR-9 in intestinal inflammation 46
Modification on ursodeoxycholic acid (UDCA) scaffold. discovery of bile acid derivatives as selective agonists of cell-surface G-protein coupled bile acid receptor 1 (GP-BAR1). 45
The Bile Acid Receptor TGR5 Maintains Gastrointestinal Homeostasis and Its Activation Rescues From Gastrointestinal Injury Caused by ASA and NSAIDs 43
VSL#3 Resets Insulin Signaling and Protects against NASH and Atherosclerosis in a Model of Genetic Dyslipidemia and Intestinal Inflammation. 40
Mechanistic role of p38 MAPK in gastric cancer dissemination in a rodent model peritoneal metastasis. 40
Hyodeoxycholic acid derivatives as liver X receptor α and G-protein-coupled bile acid receptor agonists 38
FXR Activation Corrects Immune-Dysfunction and Attenuates Inflammation in a Rodent Model of Hepatitis 37
Modification of Intestinal Microbiota by VSL#3 Protects Against Development of Pain in the Neonatal Maternal Separation Model. a Whole Genome Array Investigation 36
Totale 5.715
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.015
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.015
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021283 0 0 0 0 0 21 25 8 32 16 32 149
2021/2022676 7 132 2 34 31 7 14 223 8 32 85 101
2022/20231.223 81 243 7 124 115 116 0 62 431 1 32 11
2023/2024394 31 52 25 3 2 2 97 13 10 20 84 55
2024/20251.161 16 88 47 42 166 66 28 69 231 71 196 141
2025/20261.104 152 145 145 270 325 67 0 0 0 0 0 0
Totale 5.715